Related Experiment Video

Updated: Sep 30, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.1K

Barriers and Breakthroughs in Targeting the Oxytocin System to Treat Alcohol Use Disorder

Andrey E Ryabinin1, Yangmiao Zhang1

  • 1Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.

Frontiers in Psychiatry
|March 17, 2022
PubMed

Insights

Targeting the oxytocin system shows promise for treating alcohol use disorder (AUD). Further research is needed to refine treatments for effectively reducing alcohol consumption and cravings.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Medicine

Background:

  • Alcohol use disorder (AUD) lacks effective treatments.
  • The oxytocin peptide system is a potential therapeutic target for AUD.
  • Preclinical and initial clinical studies suggest oxytocin reduces alcohol consumption and cravings.

Purpose of the Study:

  • To review the efficacy of targeting the oxytocin system for AUD treatment.
  • To identify reasons for inconsistent clinical trial results.
  • To explore improved strategies for oxytocin-based AUD therapies.

Main Methods:

  • Review of preclinical and clinical studies on oxytocin and AUD.
  • Analysis of factors influencing oxytocin's effectiveness in humans.
  • Evaluation of three potential therapeutic approaches: increasing oxytocin potency, using receptor agonists, and stimulating endogenous oxytocin.

Main Results:

  • Oxytocin administration showed reduced alcohol consumption in rodent models.
  • Initial human studies indicated decreased alcohol craving and drinking.
  • Recent clinical trials failed to consistently replicate these positive effects, highlighting the need for nuanced approaches.

Conclusions:

  • Targeting the oxytocin system remains a promising avenue for AUD treatment.
  • Further research is essential to overcome challenges and optimize therapeutic strategies.
  • Developing more potent oxytocin analogs, receptor agonists, or endogenous system stimulators may improve treatment outcomes.
Keywords:
addictionalcohol use disorderalcoholismindividualized medicineoxytocinoxytocin receptor agonistpharmacotherapy

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.1K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
386
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
766
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
226
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.8K